Lilly Chemotherapy Drug Patent Valid, Judge Rules
A federal judge has upheld the validity of an Eli Lilly & Co. patent challenged by two generics makers that want to launch their own versions of chemotherapy drug Alimta....To view the full article, register now.
Already a subscriber? Click here to view full article